US Patent 8709415 Antibodies to OX-2/CD200 and uses thereof

Patent 8709415 was granted and assigned to Alexion Pharmaceuticals, Inc. on April, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8709415

Date of Patent

April 29, 2014

Patent Application Number

13311910

Date Filed

December 6, 2011

Patent Citations Received

‌

US Patent 11802154 Humanized anti-CD200 antibodies and uses thereof

‌

US Patent 11666645 CD200 inhibitors and methods of use thereof

‌

US Patent 11761963 Biomarker signature for predicting tumor response to anti-CD200 therapy

Patent Primary Examiner

‌

Ilia Ouspenski

Patent abstract

This application provides methods and compositions for modulating and/or depleting CD200 positive cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8709415 Antibodies to OX-2/CD200 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API